Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.32

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.18

Views

Views
October 20240
November 20242
December 20240
January 20250
February 20251
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom3
 

Top cities views

Views